<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>NIH</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Wait almost over, as SBIR nears reauthorization </title>
      <description>
        <![CDATA[A five-year reauthorization of the U.S. Small Business Innovation Research (SBIR) and Small Business Technology Transfer programs is just the president’s signature, or a few days, away.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729828</guid>
      <pubDate>Tue, 24 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729828-wait-almost-over-as-sbir-nears-reauthorization</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/newco-plant-dollar-sign.webp?t=1588285768" type="image/png" medium="image" fileSize="378693">
        <media:title type="plain">Hand holding money plant</media:title>
      </media:content>
    </item>
    <item>
      <title>US lawmakers to Bhattacharya: Explain your answers</title>
      <description>
        <![CDATA[NIH Director Jay Bhattacharya is being fact-checked on his off-the cuff responses at a Senate Health, Education, Labor and Pensions Committee hearing in February. The fact-checkers are nine Democratic lawmakers from Massachusetts, only one of whom (Sen. Ed Markey) is on the committee and attended the hearing. In fact, seven of those signing the March 17 letter that questioned Bhattacharya’s veracity aren’t senators. They serve in the House.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729760</guid>
      <pubDate>Fri, 20 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729760-us-lawmakers-to-bhattacharya-explain-your-answers</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/NIH-Director-Jay-Bhattacharya.webp?t=1774039149" type="image/jpeg" medium="image" fileSize="311688">
        <media:title type="plain">NIH Director Jay Bhattacharya</media:title>
        <media:description type="plain">NIH Director Jay Bhattacharya. Credit: https: nih.gov</media:description>
      </media:content>
    </item>
    <item>
      <title>FDA, NIH mark milestones toward reducing animal testing </title>
      <description>
        <![CDATA[In what the U.S. FDA has dubbed a milestone move toward fewer animal studies in drug development, the agency published a draft guidance to help sponsors validate new approach methodologies that can bring safe, effective drugs to market sooner based on human-centric data rather than starting off with nonclinical animal pharmacology and toxicology data.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729851</guid>
      <pubDate>Fri, 20 Mar 2026 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729851-fda-nih-mark-milestones-toward-reducing-animal-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Lab-mouse-and-test-tubes.webp?t=1762873451" type="image/jpeg" medium="image" fileSize="612519">
        <media:title type="plain">Lab mouse and test tubes</media:title>
      </media:content>
    </item>
    <item>
      <title>FDA, NIH mark milestones toward reducing animal testing </title>
      <description>
        <![CDATA[In what the U.S. FDA has dubbed a milestone move toward fewer animal studies in drug development, the agency published a draft guidance to help sponsors validate new approach methodologies that can bring safe, effective drugs to market sooner based on human-centric data rather than starting off with nonclinical animal pharmacology and toxicology data.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729565</guid>
      <pubDate>Thu, 19 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729565-fda-nih-mark-milestones-toward-reducing-animal-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Lab-mouse-and-test-tubes.webp?t=1762873451" type="image/jpeg" medium="image" fileSize="612519">
        <media:title type="plain">Lab mouse and test tubes</media:title>
      </media:content>
    </item>
    <item>
      <title>US GAO: March-ins not much of a solution for Rx prices</title>
      <description>
        <![CDATA[Driven by prescription drug prices and oft-repeated claims that nearly every drug developed in the U.S. owes its origins to taxpayer-funded research, watchdog groups and some lawmakers have led demands over the years for price to be considered a “reasonableness” factor in determining whether the government can march in on patents under the Bayh-Dole Act.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729084</guid>
      <pubDate>Thu, 19 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/729084-us-gao-march-ins-not-much-of-a-solution-for-rx-prices</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Drugs/Prescription-drug-bottles-and-pills.webp?t=1623264455" type="image/png" medium="image" fileSize="297425">
        <media:title type="plain">Prescription drug bottles and pills</media:title>
      </media:content>
    </item>
    <item>
      <title>NIH’s Bhattacharya to do double duty </title>
      <description>
        <![CDATA[U.S. NIH Director Jay Bhattacharya will be a lot busier in the days and weeks ahead. As if helming the NIH isn’t enough, Bhattacharya has been tapped to also serve as acting director of the CDC, an administration official confirmed to <em>BioWorld</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729076</guid>
      <pubDate>Wed, 18 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/729076-nihs-bhattacharya-to-do-double-duty</link>
    </item>
    <item>
      <title>All of Us hits goal of representing all of US </title>
      <description>
        <![CDATA[More than a decade after it was first proposed, the U.S. Precision Medicine Initiative that grew into the NIH’s All of Us dataset has reached its target of collecting genetic and health-related data from 1 million Americans representative of the diversity across the country.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729010</guid>
      <pubDate>Fri, 13 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/729010-all-of-us-hits-goal-of-representing-all-of-us</link>
    </item>
    <item>
      <title>NIH ends Xarelto arm of stroke trial due to safety, futility</title>
      <description>
        <![CDATA[Citing an increase in safety events and evidence of futility, the U.S. NIH stopped an investigational low-dose rivaroxaban arm of its Comparison of Anticoagulation and Antiplatelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) trial.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728878</guid>
      <pubDate>Wed, 11 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728878-nih-ends-xarelto-arm-of-stroke-trial-due-to-safety-futility</link>
    </item>
    <item>
      <title>Unburdening the past, HELPing NIH advance the future</title>
      <description>
        <![CDATA[In keeping with the congressional practice of passing major NIH reform legislation every 10 years, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee took the first step in looking at what can be for the NIH while unburdening it from what has been over the past few years.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728648</guid>
      <pubDate>Thu, 05 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728648-unburdening-the-past-helping-nih-advance-the-future</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/NIH-Biomedical-Research-Center.webp?t=1770330404" type="image/jpeg" medium="image" fileSize="1085363">
        <media:title type="plain">NIH Biomedical Research Center</media:title>
        <media:description type="plain">NIH Biomedical Research Center in Baltimore. Credit: NIH</media:description>
      </media:content>
    </item>
    <item>
      <title>Fiscal 2026 HHS spending bill in jeopardy? </title>
      <description>
        <![CDATA[After the U.S. House passed a package of spending bills Jan. 22 to fund several agencies and departments, including Health and Human Services, through fiscal 2026, the Senate was expected to quickly follow suit to ensure that no part of the federal government would shut down when the current continuing resolution expires Jan. 30. That was before a confrontation with Immigration and Customs Enforcement in Minnesota turned deadly over the weekend.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728318</guid>
      <pubDate>Mon, 26 Jan 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728318-fiscal-2026-hhs-spending-bill-in-jeopardy</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-capital-washington-congress-government.webp?t=1588689267" type="image/png" medium="image" fileSize="2212023">
        <media:title type="plain">U.S. Capitol building</media:title>
      </media:content>
    </item>
    <item>
      <title>Legislation seeks to guard NIH from politicization</title>
      <description>
        <![CDATA[The U.S. NIH may be weathering the budget storm thanks to bipartisan congressional support, but another squall line is forming on the horizon over politicization of the research agency.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728086</guid>
      <pubDate>Fri, 23 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728086-legislation-seeks-to-guard-nih-from-politicization</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/Exterior-of-NIH-Vaccine-Research-Center.webp?t=1746047246" type="image/jpeg" medium="image" fileSize="402922">
        <media:title type="plain">Exterior of NIH Vaccine Research Center</media:title>
        <media:description type="plain">The NIH's Vaccine Research Center in Bethesda, Md. Credit: Grandbrothers - stock.adobe.com</media:description>
      </media:content>
    </item>
    <item>
      <title>NIH spared slash-and-burn in congressional spending agreement </title>
      <description>
        <![CDATA[The good news is that the U.S. Congress is on track to pass a slate of fiscal 2026 spending bills before the current continuing resolution expires Jan. 30. So, barring any last-minute disputes or legislative hostage-taking, there should be no repeat of last year’s 43-day shutdown that impacted NIH grants and activities.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728147</guid>
      <pubDate>Wed, 21 Jan 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728147-nih-spared-slash-and-burn-in-congressional-spending-agreement</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-Capitol-and-100-bills.webp?t=1608670998" type="image/png" medium="image" fileSize="689551">
        <media:title type="plain">U.S. Capitol and $100 bills</media:title>
      </media:content>
    </item>
    <item>
      <title>Appeals court says no to cap on indirect costs in NIH grants</title>
      <description>
        <![CDATA[Unless the U.S. Supreme Court steps in to reverse the decision, the NIH’s attempt to cap indirect costs at 15% in all its grants is dead. The U.S. Court of Appeals for the First Circuit upheld a permanent injunction Jan. 5 that was issued by a lower court, vacating an NIH supplemental guidance imposing the across-the-board cap both retroactively and prospectively.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727863</guid>
      <pubDate>Thu, 08 Jan 2026 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727863-appeals-court-says-no-to-cap-on-indirect-costs-in-nih-grants</link>
    </item>
    <item>
      <title>Appeals court says no to cap on indirect costs in NIH grants</title>
      <description>
        <![CDATA[Unless the U.S. Supreme Court steps in to reverse the decision, the NIH’s attempt to cap indirect costs at 15% in all its grants is dead. The U.S. Court of Appeals for the First Circuit upheld a permanent injunction Jan. 5 that was issued by a lower court, vacating an NIH supplemental guidance imposing the across-the-board cap both retroactively and prospectively.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727784</guid>
      <pubDate>Tue, 06 Jan 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727784-appeals-court-says-no-to-cap-on-indirect-costs-in-nih-grants</link>
    </item>
    <item>
      <title>In 2025, science’s biggest story was political</title>
      <description>
        <![CDATA[In 2025, science saw its breakthroughs, which <em>BioWorld</em> will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about any scientific advance. It is the politicized destruction of U.S. science, and the dismantling of a scientific ecosystem that has been the envy of the world since it emerged after Germany destroyed its own pre-eminence in the 1930s.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727400</guid>
      <pubDate>Mon, 22 Dec 2025 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727400-in-2025-sciences-biggest-story-was-political</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Misc/Rubber-duck-doctor.webp?t=1766417237" type="image/jpeg" medium="image" fileSize="323965">
        <media:title type="plain">Rubber duck dressed up as a doctor</media:title>
      </media:content>
    </item>
    <item>
      <title>Scrutiny of NIH funding cuts, potential retaliation continues</title>
      <description>
        <![CDATA[Over a span of five-and-a-half months this year, 3.5% of the more than 11,000 clinical trials funded by the U.S. NIH had their grants terminated, according to an article published in the Nov. 17 <em>JAMA Internal Medicine</em>. That’s 383 trials that lost funding.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726237</guid>
      <pubDate>Mon, 17 Nov 2025 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726237-scrutiny-of-nih-funding-cuts-potential-retaliation-continues</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/dollar-sign-dropper.webp?t=1593437965" type="image/png" medium="image" fileSize="1167950">
        <media:title type="plain">Dollar sign dropper and test tube</media:title>
      </media:content>
    </item>
    <item>
      <title>One year later: funding and dealmaking in women’s health </title>
      <description>
        <![CDATA[A year ago, <em>BioWorld</em> published a special series on the women’s health drug development ecosystem, showing that while women make up half of the population, venture capital investment and life sciences partnerships in the space – specifically those deals supporting innovations for conditions primarily affecting women – pale in comparison to efforts addressing diseases more men experience. That appears to be changing, according to an updated look of <em>BioWorld</em> data, supported by findings in the Silicon Valley Bank <em>2025 Innovation in Women’s Health Report</em> published in April, and Clarivate’s Nov. 13 release of its latest Companies to Watch 2025 report, <em>Rediscovering women’s health</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726157</guid>
      <pubDate>Thu, 13 Nov 2025 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726157-one-year-later-funding-and-dealmaking-in-womens-health</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-between-hands.webp?t=1740610521" type="image/jpeg" medium="image" fileSize="123345">
        <media:title type="plain">Dollar sign between hands</media:title>
      </media:content>
    </item>
    <item>
      <title>HHS rolls the numbers as shutdown looms for US government</title>
      <description>
        <![CDATA[Despite down-to-the-wire negotiations, the odds are that parts of the U.S. government will shut down at midnight Sept. 30, as Senate Democrats refused to support a seven-week, clean continuing resolution already passed by the House to keep the government funded while Congress hammers out fiscal 2026 spending bills.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724623</guid>
      <pubDate>Tue, 30 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724623-hhs-rolls-the-numbers-as-shutdown-looms-for-us-government</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-Capitol-at-night.webp?t=1759269324" type="image/jpeg" medium="image" fileSize="854186">
        <media:title type="plain">US Capitol at night</media:title>
      </media:content>
    </item>
    <item>
      <title>Real-world data illuminates Rakuten's Alluminox solid tumor platform</title>
      <description>
        <![CDATA[Rakuten Medical Inc. is advancing a pipeline of solid tumor therapeutics built on its Alluminox platform worldwide, having gained conditional early approval of ASP-1929, an Alluminox-derived photoimmunotherapy, in Japan in 2020.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724549</guid>
      <pubDate>Fri, 26 Sep 2025 10:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724549-real-world-data-illuminates-rakutens-alluminox-solid-tumor-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Head-and-neck-anatomy.webp?t=1735588294" type="image/jpeg" medium="image" fileSize="168445">
        <media:title type="plain">Head and neck anatomy</media:title>
      </media:content>
    </item>
    <item>
      <title>NIH launches new center to replace animal testing with organoids</title>
      <description>
        <![CDATA[About five months after the U.S. FDA disclosed its roadmap to move away from animal testing in favor of new approaches for biopharma drug development, the U.S. National Institutes of Health (NIH) said it is awarding $87 million in contracts over three years to launch the Standardized Organoid Modeling Center.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724668</guid>
      <pubDate>Fri, 26 Sep 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724668-nih-launches-new-center-to-replace-animal-testing-with-organoids</link>
    </item>
    <item>
      <title>NIH launches new center to replace animal testing with organoids</title>
      <description>
        <![CDATA[About five months after the U.S. FDA disclosed its roadmap to move away from animal testing in favor of new approaches for biopharma drug development, the U.S. National Institutes of Health (NIH) said it is awarding $87 million in contracts over three years to launch the Standardized Organoid Modeling Center.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724538</guid>
      <pubDate>Thu, 25 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724538-nih-launches-new-center-to-replace-animal-testing-with-organoids</link>
    </item>
    <item>
      <title>More US federal layoffs, future of SBIR on the table</title>
      <description>
        <![CDATA[The struggle to avoid a partial U.S. government shutdown at midnight Sept. 30 is getting a lot of attention, as the stakes increase every day of the political standoff. Meanwhile, Sept. 30 also could be the end of the 43-year-old Small Business Innovation Research (SBIR) program, which has been a funding boon for biotech and med-tech startups, if Congress can’t come together on a reauthorization bill.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724536</guid>
      <pubDate>Thu, 25 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724536-more-us-federal-layoffs-future-of-sbir-on-the-table</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Misc/Hand-holding-a-pink-slip-or-termination-notice-against-a-blurred-office-background.webp?t=1739918614" type="image/jpeg" medium="image" fileSize="97603">
        <media:title type="plain">Hand holding a pink slip or termination notice against a blurred office background</media:title>
      </media:content>
    </item>
    <item>
      <title>New FDA fast track for repurposed drugs?</title>
      <description>
        <![CDATA[Breaking with its long-held, oft-recited mantra that observational studies are great for generating hypotheses but not as evidence for approval, the U.S. FDA is initiating the approval of leucovorin calcium tablets for patients with cerebral folate deficiency, a neurological condition that affects folate transfer into the brain.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724385</guid>
      <pubDate>Tue, 23 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724385-new-fda-fast-track-for-repurposed-drugs</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/FDA-icons-and-doctor.webp?t=1666903713" type="image/png" medium="image" fileSize="238204">
        <media:title type="plain">FDA icons and doctor</media:title>
      </media:content>
    </item>
    <item>
      <title>Kennedy: All US vaccines to be reviewed</title>
      <description>
        <![CDATA[Speaking at a Sept. 9 media briefing on the newly released Make America Healthy Again Strategy, U.S. Health and Human Services Secretary Robert Kennedy confirmed what could be the worst fears of many vaccine experts. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/724124</guid>
      <pubDate>Wed, 10 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724124-kennedy-all-us-vaccines-to-be-reviewed</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Vaccine-research-vial-syringe.webp?t=1670859743" type="image/png" medium="image" fileSize="1080600">
        <media:title type="plain">Vaccine vial and syringe</media:title>
      </media:content>
    </item>
    <item>
      <title>Kennedy: All US vaccines to be reviewed</title>
      <description>
        <![CDATA[Speaking at a Sept. 9 media briefing on the newly released Make America Healthy Again Strategy, U.S. Health and Human Services Secretary Robert Kennedy confirmed what could be the worst fears of many vaccine experts. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/723935</guid>
      <pubDate>Tue, 09 Sep 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723935-kennedy-all-us-vaccines-to-be-reviewed</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Vaccine-research-vial-syringe.webp?t=1670859743" type="image/png" medium="image" fileSize="1080600">
        <media:title type="plain">Vaccine vial and syringe</media:title>
      </media:content>
    </item>
    <item>
      <title>NIH support for Lactiga’s sIgA antibody for IBD</title>
      <description>
        <![CDATA[Lactiga US Inc. has received an award from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to advance the development of its secretory IgA (sIgA) antibody for inflammatory bowel disease (IBD).]]>
      </description>
      <guid>http://www.bioworld.com/articles/723908</guid>
      <pubDate>Fri, 05 Sep 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723908-nih-support-for-lactigas-siga-antibody-for-ibd</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/immunoglobulin-A-IgA.webp?t=1716994947" type="image/jpeg" medium="image" fileSize="88237">
        <media:title type="plain">Illustration of immunoglobulin A with secretory IgA</media:title>
      </media:content>
    </item>
    <item>
      <title>Stopgaps help some survive, but over time, NIH funding is unique</title>
      <description>
        <![CDATA[On Thursday, the Supreme Court handed the Trump administration another significant victory in its attempts to defund NIH-sponsored research. In a 5-4 decision, the justices paused the June 16 order of U.S. District Judge William Young to restore funding for hundreds of canceled NIH research grants focusing on gender and diversity, equity and inclusion (DEI). The funding had first been cut through a series of executive orders shortly after President Donald Trump resumed power in January.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723605</guid>
      <pubDate>Mon, 25 Aug 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723605-stopgaps-help-some-survive-but-over-time-nih-funding-is-unique</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/regulatory-washington-us-flag.webp?t=1588689518" type="image/png" medium="image" fileSize="594023">
        <media:title type="plain">U.S. flag on columned building</media:title>
      </media:content>
    </item>
    <item>
      <title>Stopgaps help some survive, but over time, NIH funding is unique</title>
      <description>
        <![CDATA[On Thursday, the Supreme Court handed the Trump administration another significant victory in its attempts to defund NIH-sponsored research. In a 5-4 decision, the justices paused the June 16 order of U.S. District Judge William Young to restore funding for hundreds of canceled NIH research grants focusing on gender and diversity, equity and inclusion (DEI). The funding had first been cut through a series of executive orders shortly after President Donald Trump resumed power in January.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723286</guid>
      <pubDate>Fri, 22 Aug 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723286-stopgaps-help-some-survive-but-over-time-nih-funding-is-unique</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/regulatory-washington-us-flag.webp?t=1588689518" type="image/png" medium="image" fileSize="594023">
        <media:title type="plain">U.S. flag on columned building</media:title>
      </media:content>
    </item>
    <item>
      <title>NIH grant supports evaluation of Trethera’s TRE-515 for lupus</title>
      <description>
        <![CDATA[Trethera Corp. has been awarded a $3 million Small Business Innovation Research (SBIR) grant from the National Institute of Health (NIH) to support evaluation of Trethera’s lead candidate, TRE-515, for the treatment of systemic lupus erythematosus (lupus).]]>
      </description>
      <guid>http://www.bioworld.com/articles/723411</guid>
      <pubDate>Wed, 20 Aug 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723411-nih-grant-supports-evaluation-of-tretheras-tre-515-for-lupus</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-in-light-bulb-on-yellow-background.webp?t=1637008317" type="image/png" medium="image" fileSize="77494">
        <media:title type="plain">Dollar sign in light bulb on yellow background</media:title>
      </media:content>
    </item>
    <item>
      <title>Lawsuit provides excuse to revive vaccine safety task force</title>
      <description>
        <![CDATA[In the wake of a lawsuit from the anti-vaccine nonprofit group U.S. Health and Human Services (HHS) Secretary Robert Kennedy founded, HHS is reviving a vaccine safety task force that’s been lifeless for nearly three decades.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723049</guid>
      <pubDate>Fri, 15 Aug 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723049-lawsuit-provides-excuse-to-revive-vaccine-safety-task-force</link>
    </item>
  </channel>
</rss>
